NIAID Centers of Excellence for Influenza Research and Response (CEIRR)

The National Institute of Allergy and Infectious Diseases seeks to establish multiple Centers of Excellence for Influenza Research and Response through cost reimbursement completion-type contracts with a period of performance of approximately seven years beginning on or around April 1, 2021. The agency intends to award up to seven contracts totaling approximately $20 million per year to create a multi-disciplinary collaborative network focused on natural history, transmission, pathogenesis and prevention and control measures. Prospective offerors must submit proposals through the NIAID electronic submission system between November 1, 2019 and the final response date specified in the forthcoming solicitation. Evaluation will consider the offeror's ability to conduct integrated basic and clinical influenza research to advance understanding and accelerate development of new control measures.

There is no set-aside designation. The primary NAICS code is 541715 and PSC code is R425. The anticipated average annual award value is $20 million per award, for a total budget of approximately $140 million over the seven year period of performance beginning December 31, 2020. The goals are to advance understanding of factors influencing influenza emergence and transmission in humans and at interspecies interfaces through cohort studies and research response capability in the event of an influenza pandemic or public health emergency.